09:48 AM EST - NeutriSci International Inc. : Announced the successful development and initial trial of the industry's first cannabinoid / pterostilbene edible tablet utilizing NeutriSci's and Lexaria's proprietary and patented technologies. NeutriSci International Inc.
shares V.NU are trading unchanged at $0.15.
